Related Experiment Videos
[Pathogenesis and therapy of shock in children (author's transl)]
Insights
Shock disrupts microcirculation, impairing vital organs and potentially leading to endotoxin shock. Early diagnosis and prompt, comprehensive therapy are crucial for improving patient outcomes in shock management.
Area of Science:
- Physiology
- Pathophysiology
- Pharmacology
Context:
- Shock is characterized by severely disturbed microcirculation.
- This leads to functional impairments in vital organs like the heart, brain, lungs, liver, kidneys, and gut.
- Gut and liver hypoperfusion can precipitate endotoxin shock even in non-endotoxin-initiated forms.
Purpose:
- To highlight the critical role of microcirculation in shock pathophysiology.
- To emphasize the necessity of early diagnosis and intervention in shock management.
- To outline key therapeutic strategies for managing shock and its complications.
Summary:
- Disturbed microcirculation in shock causes organ dysfunction, potentially leading to endotoxin shock.
- Effective shock management requires immediate therapy, even before a definitive diagnosis.
- Therapeutic priorities include volume resuscitation, preventing organ decompensation (cardiac, renal), respiratory support, direct microcirculatory improvement with vasodilators, and managing intravascular coagulation.
Impact:
- Early and targeted interventions can interrupt the shock cycle and improve prognosis.
- Comprehensive treatment addressing microcirculation and organ support is vital.
- Understanding these principles guides clinical decision-making for better shock patient outcomes.
Abstract:
The severely disturbed microcirculation characteristic of any type of shock leads to typical functional impairments in vital organs such as heart, brain, lungs, liver, kidneys and gut which, in turn, exert an adverse influence upon the process of shock. The insufficient circulation primarily of the gut and the liver causes even those forms of shock which are not initially triggered by endotoxin to develop into the ominous endotoxin shock unless rapid and effective therapy interrupts this vitious circle. The prognosis of shock depends on early diagnosis nad treatment. Therapy should be initiated even before diagnosis of the underlying disease has been completed. The following therapeutic factors require special consideration: Volume substitution, prevention of cardial decompensation and of impending uremia, prevention and treatment of respiratory failure, direct treatment of the disturbed microcirculation by means of peripherally vasodilating drugs and if necessary, suppression of the intravascular coagulation by means of plateled aggregation inhibiting, anticoagulant and fibrinolytic drugs.